| Accession Number: | 0001209191-20-049677 |
| Date: | 2020-09-03 |
| Issuer: | LIVONGO HEALTH, INC. (LVGO) |
| Original Submission Date: |
BURKE ZANE M
C/O LIVONGO HEALTH, INC.
150 WEST EVELYN AVENUE, SUITE 150
MOUNTAIN VIEW, CA 94041
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2020-09-03 | S | 49,115 | d | $124.50 | 964,838 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | represents shares sold in the open market to facilitate diversification within the reporting person's overall portfolio. following the sales reported on this form, the reporting person continues to hold approximately 85% of the vested shares of the issuer's common stock held immediately prior to such sales. |
